Xylem Reports Third Quarter 2026 Results and Announces Strategic Actions to Accelerate Growth
Xylem reported Q3 2026 revenue of $2.2 billion, down 3% reported and flat organically, but orders rose 10% organically to $2.3 billion with adjusted EPS of $1.44, up 5%. The company cut full-year guidance: revenue of ~$8.95 billion (down 1% reported vs prior +2%), adjusted EPS of $5.40-$5.45 versus $5.55-$5.70 previously, and FCF margin of ~10.2% at the low end of the prior range.
Key figures
- Eps
- 1.25
- Revenue
- 2201000000
- Guidance
- FY26 revenue ~$8.95B (down 1% reported, flat organic, vs prior +2% / +2-3% organic); adjusted EBITDA margin ~23.2%; adjusted EPS $5.40-$5.45 (down from $5.55-$5.70); FCF margin ~10.2% (vs 10.2-11.0% prior)
- Revenue Yoy
- -3% reported, flat organically
- Orders
- $2.3 billion, up 7% reported / 10% organic
- Net income
- 291000000
- Adjusted eps
- 1.44
- Net income margin
- 13.2%
- Adjusted net income
- 336000000
- Adjusted ebitda margin
- 23.9%
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.